EC
MEDP icon

Enhancing Capital’s Medpace MEDP Stock Holding History

Enhancing Capital’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$842K Buy
1,589
+127
+9% +$58.6K 0.58% 45
2026
Q1 		$702K Hold
1,462
– – 0.52% 46
2025
Q4 		$821K Sell
1,462
-84
-5% -$47.7K 0.59% 45
2025
Q3 		$795K Buy
1,546
+64
+4% +$27.9K 0.58% 48
2025
Q2 		$465K Sell
1,482
-1
-0.1% -$300 0.35% 69
2025
Q1 		$452K Buy
1,483
+49
+3% +$16.5K 0.36% 70
2024
Q4 		$476K Buy
+1,434
New +$486K 0.38% 66

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Enhancing Capital's MEDP Position: Q2 2026 in Review

Enhancing Capital increased its Medpace (MEDP) stake by 8.7% in Q2 2026, buying an estimated $58.6K and bringing the position to 1,589 shares worth $842K. The position accounts for 0.58% of the portfolio, ranked #45.

Enhancing Capital first reported a position in MEDP in Q4 2024 and has held it in 7 quarters since. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Enhancing Capital held 1,589 shares of Medpace worth $842K as of Q2 2026.
  • Enhancing Capital bought 127 Medpace shares in Q2 2026, an estimated $58.6K.
  • Medpace made up 0.58% of Enhancing Capital's portfolio in Q2 2026, its #45 holding.
  • Enhancing Capital first reported a position in Medpace in Q4 2024 and has held it in 7 quarters since.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Enhancing Capital's 13F filing for Q2 2026, filed 11 Aug 2026.